PT  - JOURNAL ARTICLE
AU  - Aguiar, Maíra
AU  - Kooi, Bob
AU  - Pugliese, Andrea
AU  - Sensi, Mattia
AU  - Stollenwerk, Nico
TI  - Time scale separation in the vector borne disease model SIRUV via center manifold analysis
AID  - 10.1101/2021.04.06.21254992
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.06.21254992
4099  - http://medrxiv.org/content/early/2021/04/09/2021.04.06.21254992.short
4100  - http://medrxiv.org/content/early/2021/04/09/2021.04.06.21254992.full
AB  - We investigate time scale separation in the vector borne disease model SIRUV, as previously described in the literature [1], and recently reanalyzed with the singular perturbation technique [2]. We focus on the analysis with a single small parameter, the birth and death rate µ, whereas all other model parameters are much larger and describe fast transitions. The scaling of the endemic stationary state, the Jacobian matrix around it and its eigenvalues with this small parameter µ is calculated and the center manifold analysis performed with the method described in [3] which goes back to earlier work [4, 5], namely a transformation of the Jacobian matrix to block structure in zeroth order in the parameter µ is used and then a family of center manifolds with µ larger than zero is obtained.Competing Interest StatementThe authors have declared no competing interest.Funding StatementM. A. has received funding from the European Unions Horizon 2020 research and innovation programme under the Marie Sk lodowska-Curie grant agreement No 792494. This research is also supported by the Basque Government through BERC 2018-2021 program and by Spanish Ministry of Sciences, Innovation and Universities: BCAM Severo Ochoa accreditation SEV-2017-0718.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB/oversight exemption for the research under consideration.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesno empirical data used.